Comparison of enalapril versus captopril on left ventricular function and survival three months after acute myocardial infarction (the "practical" Study)

The American Journal of Cardiology

Volumn 73, Issue 16, 1994, Pages 1180-1186

  Foy, Stephan G ^a,b   Crozier, Ian G ^a,b   Turner, John G ^a,b   Richards, A Mark ^a,b   Frampton, Christopher M ^a,b   Nicholls, M Gary ^a,b   Ikram, Hamid ^a,b  

^a The Princess Margaret Hospital   (New Zealand)

^b CHRISTCHURCH HOSPITAL   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

CAPTOPRIL; ENALAPRIL;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; FEMALE; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RADIOISOTOPE VENTRICULOGRAPHY; SURVIVAL;

AGED; ANGIOTENSIN II; BLOOD PRESSURE; CAPTOPRIL; CARDIAC VOLUME; CAUSE OF DEATH; COMPARATIVE STUDY; DOUBLE-BLIND METHOD; DRUG TOLERANCE; ENALAPRIL; FEMALE; FOLLOW-UP STUDIES; GATED BLOOD-POOL IMAGING; HUMAN; MALE; MIDDLE AGE; MYOCARDIAL INFARCTION; PLACEBOS; STROKE VOLUME; SURVIVAL RATE; VENTRICULAR FUNCTION, LEFT;

EID: 0028229094     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/0002-9149(94)90178-3     Document Type: Article

References (15)

1. Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction
2. Treatment of patients with symptomless left ventricular dysfunction after myocardial infarction
3. Effect of captopril on progressive ventricular dilatation after anterior myocardial infarction
4. Early prevention of left ventricular dysfunction following myocardial infarction with angiotensinconverting-enzyme inhibition
5. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction: results of the Survivial and Ventricular Enlargement Trial
6. Limitation of experimental infarct size by an angiotensin-converting enzyme inhibitor
7. Beneficial effects of the converting enzyme inhibitor, ramipril, in ischemic rat hearts
8. Differential influences of angiotensin converting-enzyme inhibitors on the coronary circulation
9. A placebo-controlled trial of combined early intravenous captopril and recombinant tissue-type plasminogen activator in acute myocardial infarction
10. Early vasodilator treatment in myocardial infarction: appropriate for the majority or minority?
11. Effects of early administration of enalapril on mortality in patients with acute myocardial infarction: results of the Cooperative New Scandinavian Enalapril Survival Study II (CONSENSUS II)
12. Effects of early captopril administration on infarct expansion, left ventricular remodelling and exercise capacity after acute myocardial infarction
13. A sensitive rapid radio-immunoasssay for angiotensin II
14. Effect of inhibition of endopeptidase 24.11 on responses to angiotensin II in human volunteers
15. Prognosis after initial myocardial infarction: the Framingham Study